Efficacy and safety of drugs for Paget's disease of bone
- 30 November 1995
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 17 (5), S485-S488
- https://doi.org/10.1016/8756-3282(95)00276-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Paget's disease of bone treated with a five day course of oral tiludronate.Annals Of The Rheumatic Diseases, 1993
- Evaluation of the efficacy and safety of oral tiludronate in paget's disease of boneArthritis & Rheumatism, 1992
- Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of BoneScandinavian Journal of Rheumatology, 1990
- Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonateClinical Rheumatology, 1989
- Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of boneBone, 1988
- Long-Term Follow-up Observations on Treatment in Paget??s Disease of BonePublished by Ovid Technologies (Wolters Kluwer Health) ,1987
- Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of boneEuropean Journal of Clinical Investigation, 1982
- Diphosphonates: History and mechanisms of actionMetabolic Bone Disease and Related Research, 1981
- Calcitonin for multiple fractures in Paget's disease.BMJ, 1977
- Ultrastructural effects of calcitonin on osteoclasts in tissue cultureJournal of Ultrastructure Research, 1972